BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31800250)

  • 1. Comparative Glycoproteomic Profiling of Human Body Fluid between Healthy Controls and Patients with Papillary Thyroid Carcinoma.
    Zhang Y; Zhao W; Zhao Y; Mao Y; Su T; Zhong Y; Wang S; Zhai R; Cheng J; Fang X; Zhu J; Yang H
    J Proteome Res; 2020 Jul; 19(7):2539-2552. PubMed ID: 31800250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Large-scale enrichment and identification of human urinary
    Shang S; Dong H; Li Y; Zhang W; Li H; Qin W; Qian X
    Se Pu; 2021 Jul; 39(7):686-694. PubMed ID: 34227365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
    Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
    J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systems analysis of singly and multiply O-glycosylated peptides in the human serum glycoproteome via EThcD and HCD mass spectrometry.
    Zhang Y; Xie X; Zhao X; Tian F; Lv J; Ying W; Qian X
    J Proteomics; 2018 Jan; 170():14-27. PubMed ID: 28970103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glyco-CPLL: An Integrated Method for In-Depth and Comprehensive N-Glycoproteome Profiling of Human Plasma.
    Zhang Y; Mao Y; Zhao W; Su T; Zhong Y; Fu L; Zhu J; Cheng J; Yang H
    J Proteome Res; 2020 Feb; 19(2):655-666. PubMed ID: 31860302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease.
    Chen Z; Yu Q; Yu Q; Johnson J; Shipman R; Zhong X; Huang J; Asthana S; Carlsson C; Okonkwo O; Li L
    Mol Cell Proteomics; 2021; 20():100081. PubMed ID: 33862227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hashimoto's Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma.
    Baser H; Ozdemir D; Cuhaci N; Aydin C; Ersoy R; Kilicarslan A; Cakir B
    Endocr Pathol; 2015 Dec; 26(4):356-64. PubMed ID: 26481630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of circulating and tissue proteomes reveals that fibronectin 1 is a potential biomarker in papillary thyroid cancer.
    Ye G; Zhang X; Li M; Lin Z; Xu Y; Dong H; Zhou J; Zhang J; Wang S; Zhu Y; Yu X; Qian X
    BMC Cancer; 2023 May; 23(1):412. PubMed ID: 37158852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide Profile Differences of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features, Encapsulated Follicular Variant, and Classical Papillary Thyroid Carcinoma: An Application of Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging.
    Ucal Y; Tokat F; Duren M; Ince U; Ozpinar A
    Thyroid; 2019 Aug; 29(8):1125-1137. PubMed ID: 31064269
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential protein expression profiles of cyst fluid from papillary thyroid carcinoma and benign thyroid lesions.
    Dinets A; Pernemalm M; Kjellin H; Sviatoha V; Sofiadis A; Juhlin CC; Zedenius J; Larsson C; Lehtiö J; Höög A
    PLoS One; 2015; 10(5):e0126472. PubMed ID: 25978681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategy integrating stepped fragmentation and glycan diagnostic ion-based spectrum refinement for the identification of core fucosylated glycoproteome using mass spectrometry.
    Cao Q; Zhao X; Zhao Q; Lv X; Ma C; Li X; Zhao Y; Peng B; Ying W; Qian X
    Anal Chem; 2014 Jul; 86(14):6804-11. PubMed ID: 24914453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary thyroid carcinoma: an easy fine needle aspiration biopsy diagnosis?
    Dušková J; Tretiník P
    Acta Cytol; 2011; 55(2):120-30. PubMed ID: 21325795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling.
    Murphy KM; Chen F; Clark DP
    Hum Pathol; 2008 Mar; 39(3):420-6. PubMed ID: 18261626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.
    Stanciu AE; Serdarevic N; Hurduc AE; Stanciu MM
    Scand J Clin Lab Invest; 2015 Nov; 75(7):539-48. PubMed ID: 26305420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto's Thyroiditis Patients and Support Total Thyroidectomy.
    Dong S; Xia Q; Wu YJ
    Otolaryngol Head Neck Surg; 2015 Jul; 153(1):20-6. PubMed ID: 25917667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hashimoto's thyroiditis and papillary thyroid carcinoma. Are cytokeratin 19 and P63 proteins of any diagnostic value?
    Divani SN; Kalodimos GP; Lioupis MA; Syrmos NC
    Hell J Nucl Med; 2016; 19(3):250-253. PubMed ID: 27824965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warthin-like papillary thyroid carcinoma with immunoglobulin G4-positive plasma cells possibly related to Hashimoto's thyroiditis.
    Hirokawa M; Nishihara E; Takada N; Higuchi M; Kotakemori M; Hayashi T; Miyauchi A
    Endocr J; 2018 Feb; 65(2):175-180. PubMed ID: 29093307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer.
    Kim SJ; Myong JP; Jee HG; Chai YJ; Choi JY; Min HS; Lee KE; Youn YK
    Head Neck; 2016 Jan; 38(1):95-101. PubMed ID: 25213729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
    Shang X; Zhong X; Tian X
    Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement.
    Pizzolanti G; Russo L; Richiusa P; Bronte V; Nuara RB; Rodolico V; Amato MC; Smeraldi L; Sisto PS; Nucera M; Bommarito A; Citarrella R; Lo Coco R; Cabibi D; Lo Coco A; Frasca F; Gulotta G; Latteri MA; Modica G; Galluzzo A; Giordano C
    Thyroid; 2007 Nov; 17(11):1109-15. PubMed ID: 17727338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.